Of the 16.7 million uninsured people who could be shopping on the Marketplace whether or not they are eligible for a subsidy; a Kaiser Family Foundation analysis estimates 4.7 million of the uninsured Americans are eligible for free ($0 premiums) Bronze plans in the ACA marketplace. The 4.7 million is also a bit less than half of the uninsured who are eligible for marketplace subsidies, according to a 2017 Kaiser estimate. Bronze plans have an average...
Read More »Michigan Senate and House Majority Republicans Will Usurp the Public’s Right to Vote on an Abortion Ban
As I pointed out in a public meeting, Republicans have had control of the Michigan Senate since 1992, the House two-thirds of the time, and the governorship two of 3 times up till Gretchen Whitmer came to office. Yet under the control of Republicans, the state’s infrastructure is crumbling, its economy has decreased when compared to other nearby competitive states, and employment Participation Rate still has not returned to what it was pre-2008 when the...
Read More »NAFTA Revision, H.R. 1865, and Biologics (Pharma) Switcheroo
Sigh . . . If the general public has not caught it, there are some of us who watch the political mechanizations by commercial healthcare to improve their lot in Congress. I know the public has not caught this switcheroo in Congress causing them to look good (and boast of it) in removing new drug exclusivity from NAFTA. What we have missed is it was granted in H.R. 1865 instead and for a longer period of time to boot. Read on to see how this was...
Read More »John Lewis should read this
American hero John Lewis has Pancreatic Cancer. He should look at these two studies of the only treatment that has actually worked and a similar treatment. Also read this article in The Lancet. and in particular “Of the 18 patients given the maximum tolerated dose, 11 (61%) achieved an objective (complete or partial) response.” American heroine Ruth Bader Ginsburg might also be interested if she has a relapse. ...
Read More »Focusing on Congressional Efforts to Control Healthcare Pricing, They Do Not
Perhaps, I am on the wrong side of the argument on how to control healthcare costs of which one proposed solution is a part of the latest budget bill passed in a bipartisan effort in Congress on December 19, 2019. Others may disagree with me on my thoughts. What was passed was superficial and will not fix the rising cost of healthcare which drives increased healthcare insurance deductibles and premiums. Oh, and surprise billing in hospitals still lives!...
Read More »Something to keep in Mind when you enroll in Medicare Advantage Plans
It is not a dirty or hidden little secret. Insurance companies offering MA plans do not tell you that once you are in their plan, you are there potentially forever. Returning to traditional Medicare is ok but, getting a Medigap Plans to supplement the gap may lead to rejection or much higher premiums if you choose to come back and especially if their are pre-existing conditions. The same as the Commercial MA companies, Medicare.gov websites are not always...
Read More »The New Pharmacy Price Transparency Rule Put Forth by President Trump
“The New Hospital Price Disclosure Rule Is Important, But Only A First Step,” Health Affairs, James C. Capretta, August 26, 2019 The new proposed regulation on hospital price transparency is an important step toward consumer-friendly price information. The regulation introduces into federal price transparency, requirements such as the concepts: of service standardization, consumer-friendly organization and terminology, and bundling of which all of are...
Read More »Another Look at Drug Pricing, Costs, and Why
Median total costs Table for the most common prescriptions of each of the 49 high-volume brand-name drugs from 2012 through 2017 as detailed in JAMA Network Open’s “Trends in Prices of Popular Brand-Name Prescription Drugs in the United States” 2019.” A Bit of A Summary: This particular table relates back to a post I wrote; Does Trump Read JAMA Network Open? which reviewed the latest JAMA findings (Trends in Prices of Popular Brand-Name Prescription Drugs...
Read More »Georgetown University Report Finds Number of Uninsured Children Now at Highest Levels –
Since Major Provisions of Affordable Care Act Took Effect Key Findings: The number of uninsured children in the United States increased by more than 400,000 between 2016 and 2018 bringing the total to over 4 million uninsured children in the nation. These coverage losses are widespread with 15 states showing statistically significant increases in the number and/or rate of uninsured children (Alabama, Arizona, Florida, Georgia, Idaho, Illinois, Indiana,...
Read More »Unsubstantiated Drug Price Increases
The ICER (Institute for Clinical and Economic Review) Is an independent and non-partisan research organization. Its purpose is to evaluate the clinical and economic value of prescription drugs, medical tests, and health care and health care delivery innovations. ICER conducts rigorous analyses of all clinical data with key stakeholders to include patients, doctors, life science companies, private insurers, and the government and translate the evidence...
Read More »